Leukotriene B4 receptor inhibitor LY293111 induces cell cycle arrest and apoptosis in human anaplastic large-cell lymphoma cells via JNK phosphorylation-Reference-Cited by-同舟云学术

Leukotriene B4 receptor inhibitor LY293111 induces cell cycle arrest and apoptosis in human anaplastic large-cell lymphoma cells via JNK phosphorylation

Published:2005-09-08 Issue:11 Volume:19 Page:1977-1984
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Zhang W,McQueen T,Schober W,Rassidakis G,Andreeff M,Konopleva M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2403929.pdf

Reference45 articles.

1. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G et al. The expression of the Hodgkin disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed–Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–858.

2. Morris SW, Xue L, Ma Z, Kinney MC . Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma. Br J Haematol 2001; 113: 275–295.

3. Falini B, Mason DY . Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry. Blood 2002; 99: 409–426.

4. Pulford K, Morris SW, Turturro F . Anaplastic lymphoma kinase proteins in growth control and cancer. J Cell Physiol 2004; 199: 330–358.

5. Andersson PO, Braide I, Nilsson-Ehle H . Trofosfamide as salvage therapy for anaplastic large cell lymphoma relapsing after high-dose chemotherapy. Leuk Lymphoma 2002; 43: 2351–2353.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophils as emerging immunotherapeutic targets: Indirect treatment of tumors by regulating the tumor immune environment based on a sialic acid derivative-modified nanocomplex platform;International Journal of Pharmaceutics;2022-05

2. Salvianolic acid A inhibits the growth of diffuse large B-cell lymphoma through MAPK pathways;Experimental Hematology;2021-02

3. Targeting Leukotrienes as a Therapeutic Strategy to Prevent Comorbidities Associated with Metabolic Stress;Druggable Lipid Signaling Pathways;2020

4. Recent advances in clinical development of leukotriene B4 pathway drugs;Seminars in Immunology;2017-10

5. Role of the tumor microenvironment in regulating apoptosis and cancer progression;Cancer Letters;2016-08